Relationship of irradiated bone marrow volume and neutropenia in patients undergoing concurrent chemoradiation therapy for cervical cancer
- 1 January 2022
- journal article
- research article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 18 (6), 1498-1503
- https://doi.org/10.4103/jcrt.jcrt_924_21
Abstract
Introduction: Concurrent chemoradiation therapy (CCRT) is the standard of care in the management of cervical cancer (International Federation of Gynecology and Obstetrics [FIGO] 2008 Stages IB2-IVA). Apart from the myelotoxic effects of chemotherapy, irradiation of pelvic bone marrow (BM) in the radiation field, can also contribute to hematological toxicity. Objectives: We examined the relationship of irradiated BM volume and neutropenia in cervical cancer patients undergoing CCRT. Materials and Methods: This prospective study was conducted in a tertiary cancer center with a longitudinal study design. A total of 43 patients undergoing CCRT for cervical cancer were included. Using auto bone segmentation, the external contour of pelvic bones from L4 vertebral body to ischial tuberosities were delineated as BM. The volume of BM receiving 10, 20, 40, 50 Gy was calculated. Complete blood counts were done weekly to evaluate the neutropenia and were graded according to Common Terminology Criteria for Adverse Events, version 3.0. The risk of developing neutropenia was analyzed using logistic regression. Results: Twenty-seven patients (62.8%) received 5 cycles of chemotherapy, 14 patients (32.6%) received 4 cycles of chemotherapy and 2 patients (4.7%) received 3 cycles of chemotherapy. Overall, 22 patients (51.2%) experienced acute neutropenia. On multivariate analysis increased BM V50Gy had a statistically significantly odds of developing any grade of neutropenia (odds ratio [OR] =1.43; 95% confidence interval [CI], 1.03–1.97; P = 0.028). When comparing patients receiving BM V40Gy ≥40% with BM V40Gy P = 0.28). Moreover, when comparing patients receiving BM V50Gy ≥15% with BM V50Gy P = 0.26). Conclusions: High-dose irradiation to the larger volume of BM prevents compensatory hyperplasia which leads to neutropenia in patients undergoing CCRT for cervical cancer.Keywords
This publication has 19 references indexed in Scilit:
- The NHV Rehabilitation Services Program Improves Long-Term Physical Functioning in Survivors of the 2008 Sichuan Earthquake: A Longitudinal Quasi ExperimentPLOS ONE, 2013
- Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinomaGynecologic Oncology, 2012
- Radiation-Related Predictors of Hematologic Toxicity After Concurrent Chemoradiation for Cervical Cancer and Implications for Bone Marrow–Sparing Pelvic IMRTInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET ImagingInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Structural and Functional Imaging of Normal Bone Marrow and Evaluation of Its Age-Related ChangesSeminars in Nuclear Medicine, 2007
- Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2006
- The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care studyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The paradoxes in patterns and mechanism of bone marrow regeneration after irradiation: 1. Different volumes and dosesRadiotherapy and Oncology, 1984
- The bone marrow organ: The critical structure in radiation-drug interactionInternational Journal of Radiation Oncology*Biology*Physics, 1978